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Hematopoietic stem cell transplantation (HSCT) is
often the only curative treatment for a wide variety
of hematologic malignancies. Donor selection in
these diseases is crucial, given that transplanted
cells can mediate not only the desired graft-versus-
leukemia effect but also graft-versus-host disease
(GVHD). Here, we demonstrate that in the absence
of NKp46, a major killer receptor expressed by hu-
man and mouse natural killer (NK) cells, GVHD is
greatly exacerbated, resulting in rapid mortality of
the transplanted animals because of infection with
commensal bacteria. Furthermore, we demonstrate
that the exacerbated GVHD is the result of an altered
ability of immune cells to respond to stimulation
by immature dendritic cells. Because high and low
expression of NKp46 on NK cells is observed in
different individuals, our data indicate that choosing
NKp46-high donors for the treatment of different
hematologic malignancies might lead to better tumor
eradication while minimizing GVHD.
INTRODUCTION
Hematopoietic stem cell transplantation (HSCT) is often the
only curative treatment for a wide variety of hematologic
malignancies. However, the transplanted cells mediate not
only the desired graft-versus-leukemia (GVL) effect but also
graft-versus-host disease (GVHD), which occurs in up to 80%
of patients in mismatch settings (Pe´rez-Simo´n et al., 2006). It is
therefore essential to select the most proper donor for HSCT,
and in this regard it is important that the donor’s major histocom-
patibility complex (MHC) proteins will be as identical as possible
to the patient’s. However, in many cases, it is impossible to
achieve a complete identity of the MHC class I proteins, and
under these conditions, allogeneic HSCT is considered, which
of course increases the chance of GVHD. Therefore, one of the
biggest challenges of allogeneic HSCT is preventing GVHDwhile
retaining the beneficial GVL effect.
Natural killer (NK) cells mediate a strong GVL effect but also
play an important role in the rejection of allogeneic transplantsC(Ruggeri et al., 2006) and GVHD (Olson et al., 2010; Shlomchik
et al., 1999).
The activity of NK cells is tightly controlled by a balance of
signals delivered by activating and inhibitory receptors, which
mostly bind to MHC class I proteins. The absence of MHC
class I molecules or mismatches between the MHC class I pro-
teins and their cognate NK inhibitory receptors can therefore
trigger NK cell activity (Jonsson and Yokoyama, 2009), as
long as the target cells expresses activating ligands (Ruggeri
et al., 2002). NKp46 is an NK cell killer receptor uniquely ex-
pressed by NK cells and a small subset of innate lymphoid cells
(Luci et al., 2009; Sanos et al., 2009). Although NKp46 has been
shown to be involved in the killing of various tumor cell lines
in vitro (Biassoni et al., 1999; Sivori et al., 1999, 2000a,
2000b; Weiss et al., 2004) and in vivo (Gazit et al., 2006; Half-
teck et al., 2009), no cellular ligand has been identified so far for
this receptor.
Human NK cells are also involved in shaping adoptive immu-
nity, as they can induce maturation of dendritic cells (DCs)
through the secretion of tumor necrosis factor a and interferon-
g (IFN-g), which are triggered by engagement of NKp30 (Vitale
et al., 2005), and, on the other hand, DCs are also able to activate
NK cells both in vitro (Koka et al., 2004) and in vivo (Lucas et al.,
2007). Surprisingly, in-vitro-activated human NK cells have been
shown to kill immature monocyte-derived DCs in a natural cyto-
toxicity receptor (NCR)-dependent manner (Ferlazzo et al., 2002;
Spaggiari et al., 2001). In contrast, mature DCs are protected
from killing, partly because of the upregulation of MHC class I
molecules during maturation (Ferlazzo et al., 2001).
Here, we show that GVHD is exacerbated in the absence
of NKp46 (Ncr1 in mice), resulting in increased tissue damage
and death due to commensal bacteria infection. This is due to
an altered ability of immune cells to respond to stimulation
by DCs.
RESULTS
Absence of Ncr1 Exacerbates GVHD
Immature dendritic cells (imDCs) are indispensable for the induc-
tion of GVHD (Shlomchik, 2007). Since we have recently shown
that NKp46 is involved in the killing of imDCs and that in the
absence of NKp46 (Ncr1) differences in the T cell responses
are observed (Ghadially et al., 2013), we hypothesized that
NKp46 could be involved in GVHD.ell Reports 7, 1809–1814, June 26, 2014 ª2014 The Authors 1809
Figure 1. Absence of NKp46 Exacerbates
Semiallogeneic GVHD
(A) (C57BL/63 BALB/c) F1 mice were injected with
2 3 107 splenocytes from Ncr1+/+ and Ncr1gfp/gfp
mice, and survival was monitored. Shown is one
representative experiment out of three performed
with nine recipient mice per group.
(B)DepletionofNKcells leads to accelerateddeath
after splenocyte transfer. NK cells were depleted
from splenocytes before transfer with comple-
ment-mediated lysis and anti-NK1.1. Shown is one
representative experiment out of two performed
with six recipient mice per group.To study this, we chose a semiallogeneic setting in which
splenocytes from wild-type C57BL/6 and Ncr1-deficient mice
(Ncr1gfp/gfp) were injected into (C57BL/6 3 BALB/c) F1 mice.
We used C57BL/6 3 BALB/c F1 mice because previous experi-
ments had shown that this leads to a relatively mild course of
GVHD (Ilan et al., 2007) and thus differences in the strength of
the reaction would be easier to identify. As expected, when sple-
nocytes fromwild-type mice were injected, the sublethally irradi-
ated recipient mice developed mild signs of GVHD over a period
of about 26 days (Figure 1A). Strikingly, when (C57BL/63 BALB/
c) F1 mice were injected with splenocytes from Ncr1
gfp/gfp mice,
defecation of soft stool and a hunched posture was observed
and all mice died within 9 to 12 days. When mice received
purified T cells, no differences between the two groups were
observed (Figure S1). The rapid mortality was not due to the ef-
fect of the irradiation, sincemice that had been irradiated but had
not received any transplant survived beyond day 56 (data not
shown). To demonstrate that this difference in the survival of
transplanted mice was indeed due to differences in NK cell func-
tion, NK cells were depleted from splenocytes prior to transplan-
tation. Importantly, in the absence of NK cells, mice that had
received splenocytes from wild-type as well as from Ncr1gfp/gfp
mice died rapidly between 10 and 12 days posttransplantation
(Figure 1B).
To find the cause of death of the mice transplanted with
Ncr1gfp/gfp splenocytes, vital organs were recovered and
analyzed histologically by staining of sections with hematoxylin
and eosin. No pathological alterations were obvious in the
lung, brain, heart, kidney, and large intestine (data not shown).
Although the liver of transplanted mice showed mild signs of
GVHD, no differences between organs of mice transplanted
with Ncr1gfp/gfp and wild-type splenocytes were found on day 9
posttransplantation (Figure S2). Importantly, significantly stron-
ger signs of GVHD were found in the skin of mice transplanted
with Ncr1gfp/gfp splenocytes, characterized by an approximately
50% increase in the number of subepidermal lymphocytes (Fig-
ure 2A). Moreover, a significantly higher amount of intraepithelial
CD3+ lymphocytes was observed in the small intestine in these
animals (Figure 2B), a higher proportion of which expressed
IFN-g (Figure S3), suggesting a significantly stronger GVHD in
mice transplanted with splenocytes from NCR1gfp/gfp mice than
from wild-type mice.
Additionally, femurs and bone marrow of transplanted mice
were examined at day 9 posttransplantation (Figure 2C). While
the femurs of mice transplanted with wild-type splenocytes con-1810 Cell Reports 7, 1809–1814, June 26, 2014 ª2014 The Authorstained relatively few cells of different hematopoietic lineages
at different stages of maturation, as is normal for regenerating
bone marrow following full-body irradiation and transplantation,
the marrow of mice transplanted with Ncr1gfp/gfp splenocytes
contained unusually large amounts of cells resembling immature
neutrophils. Since this ‘‘shift to the left’’ is indicative of an acute
infection, other parameters such as body temperature and white
blood cell counts were examined. At day 9, when mice trans-
plantedwithNcr1gfp/gfp splenocytes started to die, the body tem-
perature dropped to under 32C, while it stayed constant in mice
transplanted with wild-type splenocytes over the course of the
experiment (Figure S4). Additionally, the number of white blood
cells in the peripheral blood of these mice was more than ten
times higher than in mice transplanted with wild-type spleno-
cytes (1.56 3 108 versus 1.51 3 107 cells/ml).
Increased Inflammation in the Absence of Ncr1
As all the above mention pathologies are strong indications of
an acute infection, mice were transplanted with splenocytes
fromwild-type andNcr1gfp/gfp splenocytes as before and treated
with the broad-spectrum antibiotic Augmentin (0.2 mg/g body
weight per day) over the course of the experiment (Figure 3A).
Treatment with the antibiotic resulted in a significant increase
in the survival of mice that had received Ncr1gfp/gfp splenocytes.
While mice that had received Ncr1gfp/gfp splenocytes died within
10 to 11 days without treatment, 88% of the mice that had
received antibiotics survived for more than 23 days, indicating
that the main cause of early mortality is indeed an infection.
Treatment with the broad-spectrum antibiotic was not effective
when the treatment started 3 days after transplantation (data
not shown). To further test this possibility, on day 9 posttrans-
plantation, blood from the various animals was collected and
transferred intravenously (i.v.) into nonirradiated C57BL/6
wild-type or Ncr1gfp/gfp mice. As can be seen in Figure 3B,
mice that had received blood from mice that had been trans-
planted with wild-type splenocytes survived for the course of
the experiments and did not show any obvious signs of illness.
However, mice that had received blood from animals that had
been transplanted with Ncr1gfp/gfp splenocytes died between
day 16 and 21 posttransplantation, irrespective of whether they
expressed Ncr1 or not. This suggests that the cause of death
of mice transplanted with Ncr1gfp/gfp splenocytes is indeed an
acute infection. Moreover, in the blood of mice that had received
Ncr1gfp/gfp splenocytes, we found Citrobacter koseri (Figure S5),
which was absent from samples taken from mice transplanted
Figure 2. Exacerbated Semiallogeneic GVHD in the Absence of NKp46
(A) Hematoxylin and eosin (H&E) staining of paraffin sections of the skin of F1 mice transplanted with Ncr1+/+ and Ncr1gfp/gfp splenocytes, 10 days post-
transplantation. Original magnification310; scale bar represents 10 mm. The right graph shows number of subepidermal lymphocytes per high-power filed. Five
fields were randomly selected and counted. Shown are mean values of five fields per section from six different mice from two independent experiments (±SD).
Statistical analysis was performed with a two-tailed Student’s t test.
(B) Left: H&E staining of paraffin sections of the small intestine of F1 mice transplanted with Ncr1+/+ and Ncr1gfp/gfp splenocytes, 10 days posttransplantation.
Right: immunohistochemical staining of CD3+-expressing cells. Original magnification 3100; scale bar represents 1 mm. The right graph shows number of
subepidermal lymphocytes per high-power filed. Five fields were randomly selected and counted. Shown are mean values of five fields per section from eight
different mice from two independent experiments (±SD). Statistical analysis was performed with a two-tailed Student’s t test.
(C) H&E staining of paraffin sections of the bonemarrow of F1mice transplanted withNcr1+/+ andNcr1gfp/gfp splenocytes, 10 days posttransplantation. Left panel
is at a 3100 magnification; scale bar represents 1 mm. Right panel is at a 3200 magnification; scale bar represents 0.5 mm.with wild-type splenocytes, while no bacteria was detectable in
the blood of mice that had received wild-type splenocytes.
Indeed, when infected i.v. with a clinical isolate of C. koseri,
mice died rapidly, regardless of whether they expressed Ncr1
or not (data not shown). This indicates that the critical step in
the sepsis of mice that had received Ncr1gfp/gfp splenocytes is
the infection with commensal bacteria and not the ability to con-
trol such an infection.
Increased Proliferation of Splenocytes from Ncr1gfp/gfp
Mice after Stimulation with imBM-DCs
ImDCs are critical for the induction of GVHD (Shlomchik, 2007).
We showed recently that killing of imDCs by NK cells is depen-
dent on NKp46 but NKp46 is not involved in the direct interaction
of NK cells with T cells (Ghadially et al., 2013), and we reasoned
that the absence of NKp46/NCR1 could also have an influence
on T cell stimulation in vitro. Therefore, proliferation assays
were performed in which we initially incubated mature bone
marrow DCs from BALB/c mice as stimulators and splenocytes
from wild-type and Ncr1gfp/gfp mice, respectively, as responder,
and as expected, no differences were observed (Figure 4A). In
contrast, splenocytes from Ncr1gfp/gfp mice reacted significantly
stronger to stimulation with immature bone marrow dendritic
cells (imBM-DCs) (Figure 4B) as compared with the proliferative
response of the wild-type splenocytes. Similar results wereCobtained when splenocytes from (C57BL/6 3 BALB/c) F1 were
used as responder cells (data not shown). ImDCs are known
to be poor stimulators of T cells, and indeed the proliferative
response of the Ncr1gfp/gfp splenocytes in reaction to stimulation
by imBM-DCs was considerably weaker than the prolifera-
tion observed in response to fully mature bone marrow DCs
(compare the y axes of Figures 4A and 4B).
DISCUSSION
Dendritic cells have been shown to be indispensable for the
induction of GVHD (Shlomchik, 2007), and it was also shown
that donor-derived NK cells kill recipient DCs in the absence of
the appropriate inhibitory receptor (Ruggeri et al., 2002). Further-
more, in an allogeneic model of solid organ transplantation, it
was shown that host NK cells can kill donor-derived antigen-pre-
senting cells and that this leads to increased rejection of the graft
(Yu et al., 2006). Here we used a model of graft-versus-host
disease to investigate if the absence of NKp46 would have any
effect on the severity of the graft-versus-host reaction. Unex-
pectedly, mice transplanted with Ncr1gfp/gfp splenocytes died
rapidly in an Ncr1-dependent process mediated by NK cells,
since depletion of NK cells prior to transplantation had a similar
effect. This rapid death was due to sepsis, since severe hypo-
thermia, increased white blood cell counts, and a massive shiftell Reports 7, 1809–1814, June 26, 2014 ª2014 The Authors 1811
Figure 3. Exacerbated GVHD in the
Absence of NKp46 Leads to Sepsis
(A) Treatment with antibiotics rescues mice. After
transfer of splenocytes, mice were treated with
25 ml of 80 mg/ml Augmentin solution per os every
12 hours over the course of the experiment.
Shown is one representative experiment out of
two performedwith eight recipientmice per group.
(B) Transfer of blood from Ncr1gfp/gfp splenocyte-
transplantedmice to nonirradiatedNcr1+/+ andNcr1gfp/gfpmice leads to death. (C57BL/63BALB/c) F1 mice were injected with 23 10
7 splenocytes fromNcr1+/+
andNcr1gfp/gfpmice, respectively, and at day 9 posttransplantation, 100 ml blood from each groupwas injected i.v. into nonirradiatedNcr1+/+ andNcr1gfp/gfpmice,
respectively. Shown is one representative experiment out of two performed with five recipient mice per group.to the left in the bone marrow of these mice was observed.
Importantly, treatment of these animals with a broad-spectrum
antibiotic resulted in rescue frommortality. Furthermore, transfer
of blood from mice that had been transplanted with Ncr1gfp/gfp,
but not wild-type splenocytes, to nonirradiated mice lead to
death in these hosts, regardless of their genotype.
But what caused this sepsis? Histological analysis revealed
that tissue damage caused by GVHD was more pronounced in
the skin and the small intestine of mice that had received
Ncr1gfp/gfp cells. Moreover, we were able to identify the presence
of C. koseri in the blood of these mice, but not in those trans-
planted with wild-type splenocytes. Citrobacter spp. are gram-
negative commensal bacteria that can cause serious infections
in immunocompromised hosts, and infection with C. rodentium
in mice leads to overt symptoms such as defecation of soft stool
and a hunched posture (Vallance et al., 2003), which is similar
to what was observed in our experiments. When mice were
infected i.v. with C. koseri, all mice died and no differences
between wild-type and Ncr1gfp/gfp mice were observed. This
suggests that the differences observed in the mortality of mice
transplanted with wild-type and Ncr1gfp/gfp splenocytes are not
due to a difference in the ability of these animals to control the
infection but rather due to whether or not the pathogen reaches
the bloodstream. Importantly, and supporting these observa-
tions, it has been shown that NKp46 is not involved in the de-
fense against infection by C. rodentium (Satoh-Takayama
et al., 2009). We therefore propose that the absence of NKp46
on donor NK cells leads to increased stimulation of donor
T cells by imDCs that express unknown ligand(s) of NKp46 (Gha-
dially et al., 2013), which results in exacerbated tissue damage.
This tissue damage and the loss of the epithelial barrier function
of the small intestine leads to translocation of commensal bacte-
ria into the bloodstream and a rapid death caused by this sepsis.
A recent report (Narni-Mancinelli et al., 2012) suggested that in
a mouse in which a mutation of the Ncr1 gene had been induced
by N-ethyl-N-nitrosourea mutagenesis, NKp46-deficient NK
cells are hyperresponsive. Substantial differences exist between
the mice studied here and the Narni-Mancinelli et al. mice. While
the Ncr1gfp/gfp mice contain a deletion in the Ncr1 DNA (Gazit
et al., 2006), the other mice harbor mutations that preserve the
complete Ncr1 gene (Narni-Mancinelli et al., 2012). Furthermore,
while the complete mRNA of Ncr1 is still transcribed in the other
mice (Narni-Mancinelli et al., 2012), in the Ncr1gfp/gfp mice, it is
absent. Finally, at the protein level, the full-length Ncr1 protein
is missing in theNcr1gfp/gfpmice, while it is retained intracellularly
in mice in which the mutation of theNcr1 gene had been induced1812 Cell Reports 7, 1809–1814, June 26, 2014 ª2014 The Authorsby N-ethyl-N-nitrosourea mutagenesis (Narni-Mancinelli et al.,
2012).
Since NKp46 dull and bright phenotypes could be observed in
human populations (Sivori et al., 1999), our findings suggest that
in cases for which allogeneic transplantation is needed, the pref-
erential donors would be individuals carrying the NKp46-bright
phenotype. Furthermore, in humans, NKp30 mediates the killing
of immature DCs, and different splice forms of NKp30 have
recently been identified that have been shown to influence
DC:NK cell crosstalk. Therefore, our data suggest that bone
marrow donors could be screened for the presence of the acti-
vating NKp30 isoforms to reduce the risk of acute infection.
EXPERIMENTAL PROCEDURES
Mice
The Ncr1gfp/gfp mice were described previously (Gazit et al., 2006). All experi-
ments were done in the specific-pathogen-free unit of the Hebrew University-
Hadassah Medical School (Ein Kerem, Jerusalem) according to guidelines of
the local ethical Helsinki committee. If not stated otherwise, C57BL/6 mice
were used for the experiments.
Proliferation Assay
Bone marrow DCs were generated as described previously (Lutz et al., 1999).
Responder cells of wild-type C57BL/6 orNcr1gfp/gfpmice were plated together
with lethally irradiated (30 Gy) stimulator cells derived from BALB/c mice (5 3
105 cells/well) at the indicated ratios in a total volume of 0.2 ml medium in trip-
licate. Cultures were pulsedwith 1 mCi/well [3H]thymidine (Amersham) on day 4
and harvested 20 hr later. Cells were harvested, and thymidine uptake was
quantified in a liquid scintillation counter (TopCount NXT). Results are ex-
pressed as delta cpm (allogeneic-spontaneous).
GVHD
GVHD was induced as described previously (Ilan et al., 2007) with 750 rad
of total-body irradiation. This dose has been shown to be nonlethal in
C57BL/6 as well as in BALB/c mice. Where indicated, mice were treated
with 0.2 mg/g body weight per day with the broad-spectrum antibiotic Aug-
mentin (GlaxoSmithKline) (25 ml of 80 mg/ml per os every 12 hours) for the
course of the experiment.
For the transfer experiment, (C57BL/6 3 BALB/c) F1 were transplanted
with splenocytes fromNcr1+/+ andNcr1gfp/gfpmice, respectively, as described
above. On day 9 posttransplantation, blood was collected and 100 ml from
each group was injected i.v. into nonirradiated Ncr1+/+ and Ncr1gfp/gfp mice,
respectively.
Immunohistochemical Staining
Paraffin-embedded sections were prepared from organs of treated mice. After
antigen retrieval with citrate buffer (20 mM) in a pressure cooker (115), sec-
tions were incubated with a rat CD3 antibody (CD3-12, AbD Serotec) for
2 hr. After repeated washing, sections were incubated with Histofine simple
stain MaxPo (Rat; Nichirei Biosciences) for 30 min. Staining was achieved by
Figure 4. The Ability of Splenocytes to
React to Allogeneic Stimulation Is Impaired
in the Absence of NKp46 and Exacerbates
GVHD
Mixed-lymphocyte reactions with splenocytes
from wild-type C57BL/6 and Ncr1gfp/gfp mice as
responder cells. Mature lipopolysaccharide-stim-
ulated (1 mg/ml) BM-DCs (A) or immature BM-DCs
(B) from BALB/c mice were used as stimulators.
Results are expressed as delta cpm (allogeneic-
spontaneous) of [3H]thymidine uptake. Shown are
mean values of three independent experiments
performed in triplicate (±SD). *p = 0.005 (two-tailed
Student’s t test).incubating with 3,30-diaminobenzidine substrate (DAKO) and counterstaining
with hematoxylin.
In Vitro Complement Lysis
Splenocytes were incubated with 40 mg anti-NK1.1 (PK136, a kind gift from L.
Eisenbach) per 1 3 106 cells on ice for 30 min. After washing, the cells were
incubated in the presence of 1 ml/1 3 108 cells of rabbit complement (AbD
Serotec) for 45 min at 37C, during which they were gently agitated every
10 min. After repeated washing steps, cells were counted. Efficiency of deple-
tion, as assessed by flow cytometry with anti-CD49b (DX5), was >97%.
Statistics
Statistical analysis of the experimental data was performed with a two-tailed
Student’s t test. A value of p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2014.05.011.
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